ClinicalTrials.Veeva

Menu

Early Renal Replacement Therapy and the Outcome of Acute Kidney Injury (EarlyRRT)

C

Chulalongkorn University

Status

Completed

Conditions

Acute Renal Failure

Treatments

Procedure: continuous renal replacement therapy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This research project is a prospective study to compare mortality between early renal replacement therapy (RRT) and late renal replacement therapy by using plasma neutrophil gelatinase associated lipocalin (pNGAL) as a tool in decision- making.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient must have given his/her informed and signed consent
  • patients with acute kidney injury in the intensive care ward.

Exclusion criteria

  • The patient refuses to sign the consent
  • The patient is pregnant, parturient, or breastfeeding
  • End stage renal disease
  • Chronic renal failure
  • previous kidney transplant

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 3 patient groups

High NGAL and early RRT
Experimental group
Description:
NGAL level \> 400 ng/ml and start continuous renal replacement therapy early
Treatment:
Procedure: continuous renal replacement therapy
High NGAL and late RRT
Experimental group
Description:
NGAL \> 400 ng/ml and start continuous renal replacement therapy late
Treatment:
Procedure: continuous renal replacement therapy
Low NGAL
Active Comparator group
Description:
NGAL \< 400 ng/ml and starting continuous renal replacement therapy follow with absolute indication
Treatment:
Procedure: continuous renal replacement therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems